Livforsakringsbolaget Skandia’s Gilead Sciences GILD Stock Holding History

Livforsakringsbolaget Skandia’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.17M	Hold	8,417	–	–	0.05%	154
2025 Q4	$1.03M	Sell	8,417 -700	-8%	-$85.1K	0.04%	176
2025 Q3	$1.01M	Sell	9,117 -400	-4%	-$45.5K	0.04%	189
2025 Q2	$1.05M	Hold	9,517	–	–	0.05%	185
2025 Q1	$1.07M	Sell	9,517 -800	-8%	-$82.5K	0.06%	191
2024 Q4	$953K	Sell	10,317 -400	-4%	-$36K	0.05%	194
2024 Q3	$898K	Buy	10,717 +8,565	+398%	+$654K	0.05%	206
2024 Q2	$148K	Sell	2,152 -98,220	-98%	-$6.55M	0.01%	250
2024 Q1	$7.35M	Hold	100,372	–	–	0.62%	43
2023 Q4	$8.13M	Buy	100,372 +1,235	+1%	+$96.1K	0.78%	28
2023 Q3	$7.43M	Sell	99,137 -4,600	-4%	-$354K	0.82%	26
2023 Q2	$7.99M	Sell	103,737 -10,500	-9%	-$837K	0.83%	25
2023 Q1	$9.48M	Hold	114,237	–	–	0.99%	20
2022 Q4	$9.8M	Hold	114,237	–	–	1.13%	14
2022 Q3	$7.05M	Sell	114,237 -21,000	-16%	-$1.32M	0.87%	26
2022 Q2	$8.36M	Sell	135,237 -2,800	-2%	-$173K	0.73%	33
2022 Q1	$8.21M	Hold	138,037	–	–	0.55%	43
2021 Q4	$10M	Buy	138,037 +36,300	+36%	+$2.5M	0.64%	34
2021 Q3	$7.1M	Sell	101,737 -2,300	-2%	-$162K	0.44%	52
2021 Q2	$7.16M	Buy	104,037 +6,700	+7%	+$447K	0.43%	55
2021 Q1	$6.29M	Buy	97,337 +12,200	+14%	+$787K	0.44%	56
2020 Q4	$4.96M	Buy	85,137 +5,600	+7%	+$338K	0.42%	52
2020 Q3	$5.03M	Sell	79,537 -1,000	-1%	-$69.3K	0.54%	42
2020 Q2	$6.2M	Hold	80,537	–	–	0.71%	29
2020 Q1	$6.02M	Buy	80,537 +4,100	+5%	+$283K	0.85%	24
2019 Q4	$4.97M	Sell	76,437 -5,700	-7%	-$371K	0.59%	38
2019 Q3	$5.21M	Hold	82,137	–	–	0.62%	33
2019 Q2	$5.55M	Buy	82,137 +2,600	+3%	+$171K	0.68%	32
2019 Q1	$5.17M	Buy	79,537 +1,300	+2%	+$86.4K	0.68%	32
2018 Q4	$4.89M	Hold	78,237	–	–	0.73%	32
2018 Q3	$6.04M	Sell	78,237 -25,300	-24%	-$1.91M	0.72%	27
2018 Q2	$7.33M	Buy	103,537 +3,400	+3%	+$240K	0.67%	29
2018 Q1	$7.55M	Hold	100,137	–	–	0.73%	25
2017 Q4	$7.17M	Sell	100,137 -10,500	-9%	-$797K	0.69%	29
2017 Q3	$8.96M	Hold	110,637	–	–	0.8%	24
2017 Q2	$7.83M	Hold	110,637	–	–	0.72%	30
2017 Q1	$7.51M	Sell	110,637 -49,700	-31%	-$3.49M	0.7%	32
2016 Q4	$11.5K	Buy	160,337 +124,858	+352%	+$9.28M	0.58%	34
2016 Q3	$4.99M	Sell	35,479 -171,658	-83%	-$13.9M	0.24%	97
2016 Q2	$17.3M	Sell	207,137 -2,500	-1%	-$222K	0.77%	28
2016 Q1	$19.3M	Hold	209,637	–	–	0.9%	19
2015 Q4	$21.2M	Buy	209,637 +49,300	+31%	+$5.13M	1%	17
2015 Q3	$15.7M	Buy	160,337 +7,520	+5%	+$835K	0.83%	22
2015 Q2	$17.9M	Buy	152,817 +7,000	+5%	+$765K	0.88%	19
2015 Q1	$14.3M	Sell	145,817 -9,600	-6%	-$975K	0.7%	27
2014 Q4	$14.7M	Sell	155,417 -52,300	-25%	-$5.41M	0.68%	25
2014 Q3	$22.1M	Sell	207,717 -15,200	-7%	-$1.49M	0.83%	19
2014 Q2	$18.5M	Hold	222,917	–	–	0.66%	28
2014 Q1	$15.8M	Buy	+222,917	New	+$17.5M	0.59%	33

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Livforsakringsbolaget Skandia's GILD Position: Q1 2026 in Review

Livforsakringsbolaget Skandia held its Gilead Sciences (GILD) position steady in Q1 2026 at 8,417 shares worth $1.17M. The position accounts for 0.05% of the portfolio, ranked #154.

Livforsakringsbolaget Skandia first reported a position in GILD in Q1 2014 and has held it in 49 quarters since. The position peaked at $22.1M in Q3 2014. 2,316 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Livforsakringsbolaget Skandia held 8,417 shares of Gilead Sciences worth $1.17M as of Q1 2026.
Livforsakringsbolaget Skandia left its Gilead Sciences share count unchanged in Q1 2026.
Gilead Sciences made up 0.05% of Livforsakringsbolaget Skandia's portfolio in Q1 2026, its #154 holding.
Livforsakringsbolaget Skandia first reported a position in Gilead Sciences in Q1 2014 and has held it in 49 quarters since.
Livforsakringsbolaget Skandia's Gilead Sciences position peaked at $22.1M in Q3 2014.
2,316 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Livforsakringsbolaget Skandia's 13F filing for Q1 2026, filed 5 May 2026.